Angola vs Sur: Hepatitis B surface antigen (HBsAg) prevalence (%)
Angola
3.1%
in 2024
Sur
0.2%
in 2024
Angola rank
5th
Sur rank
2nd
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Angola
- Sur
How they compare
Angola currently reports 3.1% against 0.2% in Sur, a difference of 2.9%.
That makes Angola's figure about 15.5 times Sur's.
Across all 10 years both countries report, Angola has been ahead every year.
Angola ranks 5th and Sur ranks 2nd of 194 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.2% | 2.4% | Angola |
| 2020s | 3.0% | 0.2% | 2.8% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Angola or Sur?
- Angola, at 3.1% against 0.2% in Sur as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Angola and Sur?
- 2.9%, with Angola ahead.
- How many years of comparable data are there for Angola and Sur?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Sur rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Angola ranks 5th and Sur ranks 2nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.